PL
AZN icon

Parkwood LLC’s AstraZeneca AZN Stock Holding History

Parkwood LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5M Buy
+58,982
New +$11.4M 1.02% 42
2025
Q3 		– Sell
-109,588
Closed -$15.3M – 87
2025
Q2 		$15.3M Buy
109,588
+56,026
+105% +$7.85M 1.37% 19
2025
Q1 		$7.87M Sell
53,562
-5,538
-9% -$801K 0.72% 49
2024
Q4 		$7.74M Buy
59,100
+22,757
+63% +$3.19M 0.88% 53
2024
Q3 		$5.66M Buy
36,343
+7,323
+25% +$1.18M 0.4% 56
2024
Q2 		$4.53M Sell
29,020
-12,234
-30% -$1.84M 0.56% 56
2024
Q1 		$5.59M Sell
41,254
-49,364
-54% -$6.54M 0.5% 62
2023
Q4 		$12.2M Sell
90,618
-5,118
-5% -$665K 1.46% 18
2023
Q3 		$13M Buy
95,736
+9,491
+11% +$1.3M 1.41% 10
2023
Q2 		$12.3M Sell
86,245
-1,688
-2% -$248K 2.25% 8
2023
Q1 		$12.2M Buy
87,933
+16,163
+23% +$2.17M 1.68% 12
2022
Q4 		$9.73M Sell
71,770
-2,016
-3% -$253K 1.48% 11
2022
Q3 		$8.09M Buy
73,786
+3,422
+5% +$434K 1.23% 17
2022
Q2 		$9.3M Sell
70,364
-20,550
-23% -$2.7M 1.66% 10
2022
Q1 		$12.1M Buy
90,914
+1,673
+2% +$201K 1.98% 11
2021
Q4 		$10.4M Sell
89,241
-52,005
-37% -$6.12M 1.77% 9
2021
Q3 		$17M Sell
141,246
-24,539
-15% -$2.86M 2.05% 4
2021
Q2 		$19.9M Buy
165,785
+31,458
+23% +$3.45M 2.3% 4
2021
Q1 		$13.4M Buy
134,327
+11,335
+9% +$1.14M 2.36% 6
2020
Q4 		$12.3M Buy
122,992
+107,077
+673% +$11.3M 1.49% 14
2020
Q3 		$9.36M Sell
15,915
-88,432
-85% -$9.84M 1.44% 16
2020
Q2 		$11M Sell
104,347
-24,557
-19% -$2.54M 1.98% 9
2020
Q1 		$11.5M Sell
128,904
-6,568
-5% -$618K 2.34% 7
2019
Q4 		$13.5M Sell
135,472
-21,353
-14% -$2.01M 2.83% 4
2019
Q3 		$14M Buy
156,825
+85,660
+120% +$7.43M 2.82% 5
2019
Q2 		$5.88M Sell
71,165
-1,335
-2% -$105K 1.25% 30
2019
Q1 		$5.86M Buy
+72,500
New +$5.71M 1.15% 29
2017
Q1 		– Sell
-50,464
Closed -$2.76M – 498
2016
Q4 		$2.76M Buy
+50,464
New +$2.87M 0.42% 62
2015
Q3 		– Sell
-23,876
Closed -$1.52M – 497
2015
Q2 		$1.52M Sell
23,876
-60,241
-72% -$4.12M 0.21% 50
2015
Q1 		$5.76M Buy
84,117
+6,365
+8% +$442K 0.72% 38
2014
Q4 		$5.47M Buy
77,752
+1,242
+2% +$88.9K 0.75% 38
2014
Q3 		$5.47M Buy
76,510
+920
+1% +$67.3K 1.15% 27
2014
Q2 		$5.62M Sell
75,590
-23,549
-24% -$1.7M 1.3% 23
2014
Q1 		$6.43M Buy
99,139
+13,365
+16% +$863K 1.55% 15
2013
Q4 		$5.09M Buy
+85,774
New +$4.66M 1.28% 17

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Parkwood LLC's AZN Position: Q1 2026 in Review

Parkwood LLC opened a new position in AstraZeneca (AZN) in Q1 2026: 58,982 shares worth $11.5M. The stake represents 1.02% of the portfolio and ranks #42 among its holdings. This is a return to the name: Parkwood LLC previously reported a position in AZN as recently as Q2 2025.

Parkwood LLC first reported a position in AZN in Q4 2013 and has held it in 35 quarters since. The position peaked at $19.9M in Q2 2021. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Parkwood LLC held 58,982 shares of AstraZeneca worth $11.5M as of Q1 2026.
  • AstraZeneca was a new Parkwood LLC position in Q1 2026.
  • AstraZeneca made up 1.02% of Parkwood LLC's portfolio in Q1 2026, its #42 holding.
  • Parkwood LLC first reported a position in AstraZeneca in Q4 2013 and has held it in 35 quarters since.
  • Parkwood LLC's AstraZeneca position peaked at $19.9M in Q2 2021.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Parkwood LLC's 13F filing for Q1 2026, filed 15 May 2026.